Solange Meyer

942 total citations
19 papers, 682 citations indexed

About

Solange Meyer is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Solange Meyer has authored 19 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 7 papers in Computational Theory and Mathematics and 6 papers in Infectious Diseases. Recurrent topics in Solange Meyer's work include Malaria Research and Control (12 papers), Computational Drug Discovery Methods (7 papers) and HIV/AIDS drug development and treatment (6 papers). Solange Meyer is often cited by papers focused on Malaria Research and Control (12 papers), Computational Drug Discovery Methods (7 papers) and HIV/AIDS drug development and treatment (6 papers). Solange Meyer collaborates with scholars based in Switzerland, Canada and United States. Solange Meyer's co-authors include Daniel Bur, Christoph A. Binkert, Christoph Boss, François Diederich, Thomas Weller, Walter Fischli, Sylvia Richard‐Bildstein, Lars Prade, Andrew F. Jones and Fraser Hof and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Solange Meyer

19 papers receiving 676 citations

Peers

Solange Meyer

PHEOH

CTM

PRM

Wonsuk Chang United States

Edward F. Elslager United States

Marco A. Biamonte United States

Daniel Muthas Sweden

Yong Nian China

Hon C. Hui United States

Joanne M. Smallheer United States

Adrian Blaser New Zealand

Jutta Wanner United States

Malcolm EAST United Kingdom

Wonsuk Chang United States

Solange Meyer

206 ×0.8

PHEOH

435 ×1.9

571 ×2.6

115 ×0.6

CTM

9 ×0.1

PRM

Citations per year, relative to Solange Meyer Solange Meyer (= 1×) peers Wonsuk Chang

Countries citing papers authored by Solange Meyer

Since Specialization

Citations

This map shows the geographic impact of Solange Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solange Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solange Meyer more than expected).

Fields of papers citing papers by Solange Meyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solange Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solange Meyer. The network helps show where Solange Meyer may publish in the future.

Co-authorship network of co-authors of Solange Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Solange Meyer. A scholar is included among the top collaborators of Solange Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solange Meyer. Solange Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Huang, Chia‐Ying, A. Metz, Roland Lange, et al.. (2024). Fragment-based screening targeting an open form of the SARS-CoV-2 main protease binding pocket. Acta Crystallographica Section D Structural Biology. 80(2). 123–136. 8 indexed citations

Bolli, Martin H., Stefan Abele, Magdalena Birker, et al.. (2013). Novel S1P₁ Receptor Agonists – Part 1: From Pyrazoles to Thiophenes. Journal of Medicinal Chemistry. 56(23). 9737–9755. 18 indexed citations

Bolli, Martin H., Magdalena Birker, Roberto Bravo, et al.. (2013). Novel S1P₁ Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes. Journal of Medicinal Chemistry. 57(1). 78–97. 9 indexed citations

Ciana, Claire‐Lise, Romain Siegrist, Hamed Aissaoui, et al.. (2012). Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold. Bioorganic & Medicinal Chemistry Letters. 23(3). 658–662. 32 indexed citations

Ehmke, Veronika, W. Bernd Schweizer, Bruno Bernet, et al.. (2012). Potent Inhibitors of Malarial Aspartic Proteases, the Plasmepsins, by Hydroformylation of Substituted 7‐Azanorbornenes. Chemistry - A European Journal. 19(1). 155–164. 14 indexed citations

Aissaoui, Hamed, Christoph Boss, Zbynek Bozdech, et al.. (2012). Identification of a New Chemical Class of Antimalarials. The Journal of Infectious Diseases. 206(5). 735–743. 25 indexed citations

Bolli, Martin H., Christoph Boss, Christoph A. Binkert, et al.. (2012). The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist. Journal of Medicinal Chemistry. 55(17). 7849–7861. 123 indexed citations

Hardegger, Leo A., et al.. (2010). Enantiomerically Pure and Highly Substituted Alicyclic α,α‐Difluoro Ketones: Potential Inhibitors for Malarial Aspartic Proteases, the Plasmepsins. European Journal of Organic Chemistry. 2010(24). 4617–4629. 19 indexed citations

Hardegger, Leo A., Lukas Baitsch, W. Bernd Schweizer, et al.. (2009). New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic α,α-difluoroketone hydrates. Organic & Biomolecular Chemistry. 7(19). 3947–3947. 42 indexed citations

10.

Hof, Fraser, Andri Schütz, W. Bernd Schweizer, et al.. (2009). Synthesis of exo‐3‐Amino‐7‐azabicyclo[2.2.1]heptanes as a Class of Malarial Aspartic Protease Inhibitors: Exploration of Two Binding Pockets. European Journal of Organic Chemistry. 2009(11). 1707–1719. 12 indexed citations

11.

Meyer, Solange, et al.. (2007). Exploring the Flap Pocket of the Antimalarial Target Plasmepsin II: The “55 % Rule” Applied to Enzymes. ChemMedChem. 3(2). 237–240. 38 indexed citations

12.

Hof, Fraser, Andri Schütz, Solange Meyer, et al.. (2006). Starving the Malaria Parasite: Inhibitors Active against the Aspartic Proteases Plasmepsins I, II, and IV. Angewandte Chemie International Edition. 45(13). 2138–2141. 74 indexed citations

13.

Corminboeuf, Olivier, Corinna Grisostomi, Solange Meyer, et al.. (2006). Inhibitors of Plasmepsin II—potential antimalarial agents. Bioorganic & Medicinal Chemistry Letters. 16(24). 6194–6199. 14 indexed citations

14.

Boss, Christoph, Olivier Corminboeuf, Corinna Grisostomi, et al.. (2006). Achiral, Cheap, and Potent Inhibitors of Plasmepsins I, II, and IV. ChemMedChem. 1(12). 1341–1345. 43 indexed citations

15.

Hof, Fraser, Andri Schütz, Solange Meyer, et al.. (2006). Aushungern des Malaria‐Erregers: Hemmer der Aspartylproteasen Plasmepsin I, II und IV. Angewandte Chemie. 118(13). 2193–2196. 25 indexed citations

16.

Prade, Lars, Andrew F. Jones, Christoph Boss, et al.. (2005). X-ray Structure of Plasmepsin II Complexed with a Potent Achiral Inhibitor. Journal of Biological Chemistry. 280(25). 23837–23843. 75 indexed citations

17.

Binkert, Christoph A., Andrew F. Jones, Solange Meyer, et al.. (2005). Replacement of Isobutyl by Trifluoromethyl in Pepstatin A Selectively Affects Inhibition of Aspartic Proteinases. ChemBioChem. 7(1). 181–186. 30 indexed citations

18.

Boss, Christoph, Reto Brun, Walter Fischli, et al.. (2004). Inhibitors of Plasmepsin II – Potential Antimalarial Agents. CHIMIA International Journal for Chemistry. 58(9). 634–634. 5 indexed citations

19.

Boss, Christoph, Sylvia Richard‐Bildstein, Thomas Weller, et al.. (2003). Inhibitors of the Plasmodium Falciparum Parasite Aspartic Protease Plasmepsin II As Potential Antimalarial Agents. Current Medicinal Chemistry. 10(11). 883–907. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact